Regulator

Summary of regulator annotations and link-out to annotation databases

Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.

ELK3 - ETS transcription factor ELK3

Function

May be a negative regulator of transcription, but can activate transcription when coexpressed with Ras, Src or Mos. Forms a ternary complex with the serum response factor and the ETS and SRF motifs of the Fos serum response element.

Uniprot Browser
Entrez IDEnsEMBL IDPreferred NameUniprot ID
2004 ENSG00000111145 ELK3 P41970

List of causal flows containing the regulator.

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows with ENSG00000111145 as Regulator

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-08285KIF4Adown-regulatesELK3activatesR-361021Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-09515DOCK11up-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-12301GPR98down-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-15667DCHS2up-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-16569RBM19down-regulatesELK3activatesR-361021Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-19439NF1up-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-22646IDH1down-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-24835SULT1B1up-regulatesELK3activatesR-361021Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-25516EPHX4down-regulatesELK3activatesR-361021Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-31839EPHB_FORWARD_SIGNALINGup-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-32887EPHA2_FORWARD_SIGNALINGup-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB

CMF-33242EPHRIN_B_REVERSE_SIGNALINGup-regulatesELK3activatesR-361022Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

TIGATUZUMAB, CONATUMUMAB, DULANERMIN, LEXATUMUMAB, DROZITUMAB